|Day's Range||64.80 - 65.62|
|52 Week Range||55.06 - 68.12|
|PE Ratio (TTM)||16.96|
|Earnings Date||Jul 27, 2017 - Jul 31, 2017|
|Dividend & Yield||2.56 (3.90%)|
|1y Target Est||72.28|
Why AbbVie, Pfizer, and Johnson & Johnson rank as the best dividend stocks among arthritis medication companies.
Like its rivals Cardinal Health (No. 7) and McKesson (No. 73), Amerisource has been buffeted by Wall Street’s concerns about pricing pressure on branded and generic drugs. SEE THE FULL LIST OF THE BARRON’S 500 Amerisource (ABC) “is a key cog within the pharmaceutical industry, as many other supply-chain participants are dependent upon its services for streamlined product distribution and procurement,” notes Vishnu Lekraj, a Morningstar analyst. Sales growth, as it happens, is one of three components in our annual ranking, which spotlights companies that do the best job of boosting revenue and investing for growth.
The Zacks Analyst Blog Highlights: Boeing, AbbVie, UnitedHealth, Consolidated Edison and Cisco